American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1.
Dawn M WaheziMindy S LoTamar B RubinsteinSarah RingoldStacy P ArdoinKevin J DownesKarla B JonesRonald M LaxerRebecca Pellet MadanAmy S MudanoAmy S TurnerEdward M BehrensJay J MehtaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
These guidance statements have been generated based on review of the available literature, indicating that children with PRD do not appear to be at increased risk for susceptibility to SARS-CoV-2 infection. This guidance is presented as a "living document," recognizing that the literature on COVID-19 is rapidly evolving, with future updates anticipated.